An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that rely only on public data, according to a Nature report by Ewen Callaway…
Scientists have used artificial intelligence to design novel, viable viruses, a breakthrough celebrated as a major advance against antibiotic resistance but raising urgent regulatory concerns, accordi…
The knowledge and infrastructure needed to engineer a pandemic pathogen are becoming more accessible, according to Henry I. Miller in Quillette on August 30, 2026, raising concerns about AI-enabled bi…
Big Pharma's second-quarter earnings calls highlighted the growing role of AI in drug development and the intensifying oral GLP-1 competition between Novo Nordisk and Eli Lilly, alongside leadership c…
AI is becoming a dominant force in biopharma, with advocates and investors touting it as a transformative technology for drug R&D, while skeptics remain cautious. The discussion marks a shift from abs…
Generative AI is emerging as a tool to translate raw personal health data from wearable devices into actionable insights, addressing the Quantified Self movement's long-standing problem of data withou…
The FDA advisory committee's vote against Capricor Therapeutics' cell therapy for Duchenne muscular dystrophy highlights a broader challenge: precision medicine shrinks patient populations, making tra…